These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 33895188)
21. Diverse Thiophenes as Scaffolds in Anti-cancer Drug Development: A Concise Review. Bhilare NV; Auti PB; Marulkar VS; Pise VJ Mini Rev Med Chem; 2021; 21(2):217-232. PubMed ID: 33267760 [TBL] [Abstract][Full Text] [Related]
22. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer. Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065 [TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009. Poulsen SA Expert Opin Ther Pat; 2010 Jun; 20(6):795-806. PubMed ID: 20476848 [TBL] [Abstract][Full Text] [Related]
24. Novel sulfonamide compounds for inhibition of metastatic tumor growth (WO2012021963). Colinas PA Expert Opin Ther Pat; 2013; 23(6):761-3. PubMed ID: 23566197 [TBL] [Abstract][Full Text] [Related]
25. Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases. Elzahhar PA; Abd El Wahab SM; Elagawany M; Daabees H; Belal ASF; El-Yazbi AF; Eid AH; Alaaeddine R; Hegazy RR; Allam RM; Helmy MW; Bahaa Elgendy ; Angeli A; El-Hawash SA; Supuran CT Eur J Med Chem; 2020 Aug; 200():112439. PubMed ID: 32485532 [TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895 [TBL] [Abstract][Full Text] [Related]
27. Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box. Martins P; Jesus J; Santos S; Raposo LR; Roma-Rodrigues C; Baptista PV; Fernandes AR Molecules; 2015 Sep; 20(9):16852-91. PubMed ID: 26389876 [TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles. Nocentini A; Cadoni R; Dumy P; Supuran CT; Winum JY J Enzyme Inhib Med Chem; 2018 Dec; 33(1):286-289. PubMed ID: 29278948 [TBL] [Abstract][Full Text] [Related]
29. Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII. Bonardi A; Falsini M; Catarzi D; Varano F; Di Cesare Mannelli L; Tenci B; Ghelardini C; Angeli A; Supuran CT; Colotta V Eur J Med Chem; 2018 Feb; 146():47-59. PubMed ID: 29407972 [TBL] [Abstract][Full Text] [Related]
30. Natural product polyamines that inhibit human carbonic anhydrases. Davis RA; Vullo D; Supuran CT; Poulsen SA Biomed Res Int; 2014; 2014():374079. PubMed ID: 25162012 [TBL] [Abstract][Full Text] [Related]
31. Bioactive heterocycles containing a 3,4,5-trimethoxyphenyl fragment exerting potent antiproliferative activity through microtubule destabilization. Fu DJ; Yang JJ; Li P; Hou YH; Huang SN; Tippin MA; Pham V; Song L; Zi X; Xue WL; Zhang LR; Zhang SY Eur J Med Chem; 2018 Sep; 157():50-61. PubMed ID: 30075402 [TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities. Akhtar J; Khan AA; Ali Z; Haider R; Shahar Yar M Eur J Med Chem; 2017 Jan; 125():143-189. PubMed ID: 27662031 [TBL] [Abstract][Full Text] [Related]
33. Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities. Akhtar MJ; Yar MS; Khan AA; Ali Z; Haider MR Mini Rev Med Chem; 2017; 17(17):1602-1632. PubMed ID: 27804888 [TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894 [TBL] [Abstract][Full Text] [Related]
36. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery. Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996 [TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrase inhibitors: synthesis of N-morpholylthiocarbonylsulfenylamino aromatic/heterocyclic sulfonamides and their interaction with isozymes I, II and IV. Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2000 May; 10(10):1117-20. PubMed ID: 10843231 [TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Vullo D; Franchi M; Gallori E; Pastorek J; Scozzafava A; Pastorekova S; Supuran CT Bioorg Med Chem Lett; 2003 Mar; 13(6):1005-9. PubMed ID: 12643899 [TBL] [Abstract][Full Text] [Related]
39. Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids. Luisi G; Angelini G; Gasbarri C; Laghezza A; Agamennone M; Loiodice F; Supuran CT; Campestre C; Tortorella P J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1260-1264. PubMed ID: 28948845 [TBL] [Abstract][Full Text] [Related]